Physician profile
Amanda Munoz
NPI 1841601796
$4,507.58
in general payments reported to CMS, 2019-2025
26 companies · $2,042 in 2025
The $2,042 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $204 · 2021: $565 · 2022: $853 · 2023: $131 · 2024: $232 · 2025: $2,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $905.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,518.17 | 2025 | |
| Abbvie INC. | $515.79 | 2019-2022 | |
| Agile Therapeutics, INC. | $325.47 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $224.85 | 2020-2025 | Veozah |
| Therapeuticsmd, INC. | $208.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $208.46 | 2019-2024 | |
| Myovant Sciences INC. | $206.81 | 2021-2022 | |
| Aspira Women'S Health INC | $181.69 | 2022 | |
| Mayne Pharma Commercial LLC | $167.23 | 2025 | |
| Sumitomo Pharma America, INC. | $157.57 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $138.00 | 2020-2024 | Myosure Tissue Removal Device, Coolseal Generator, Acessa Provu System |
| Organon LLC | $121.61 | 2021-2024 | |
| Biogen, INC. | $68.13 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $65.23 | 2020-2024 | Advincula Delineator Uterine Manipulator |
| Exeltis, USA INC. | $59.86 | 2022-2025 | Slynd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $48.33 | 2022-2025 | |
| Covidien Lp | $43.47 | 2019 | |
| Merck Sharp & Dohme LLC | $39.95 | 2019-2021 | |
| Roche Diagnostics Corporation | $36.56 | 2019 | |
| Evofem Biosciences, INC. | $34.99 | 2021 | |
| Minerva Surgical, INC | $33.43 | 2019 | |
| Mylan Pharmaceuticals INC. | $25.70 | 2020 | |
| Daiichi Sankyo INC. | $25.66 | 2022 | |
| Dexcom, INC. | $25.30 | 2025 | Dexcom G6 Transmitter |
| Dysis Medical, INC. | $13.77 | 2020 | |
| Allergan, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.